The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived …
…, M Chaari, V Galea, A Khaterchi… - Thrombosis and …, 2012 - thieme-connect.com
Sickle cell disease (SCD) is linked to hypercoagulability and is characterised by high
concentrations of erythrocyte-derived microparticles (Ed-MPs). However, the impact of …
concentrations of erythrocyte-derived microparticles (Ed-MPs). However, the impact of …
Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department
…, B Pilmis, A Mizrahi, GP de Ponfilly, A Khaterchi… - Journal of Clinical …, 2021 - Elsevier
Background Rapid testing for COVID-19 has been clearly identified as an essential component
of the strategy to control the SARS-CoV-2 epidemic, worldwide. The ID NOW COVID-19 …
of the strategy to control the SARS-CoV-2 epidemic, worldwide. The ID NOW COVID-19 …
Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability
…, F Sidibe, H Ketatni, V Galea, A Khaterchi… - BMC cancer, 2014 - Springer
Background In breast cancer patients routine thromboprophylaxis is not recommended but
individualized risk assessment is encouraged. The incorporation of hypercoagulability …
individualized risk assessment is encouraged. The incorporation of hypercoagulability …
Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: confirmation in a …
V Galea, A Khaterchi, F Robert, G Gerotziafas, M Hatmi… - Platelets, 2013 - Taylor & Francis
Heparin-induced thrombocytopenia (HIT) is a potentially lethal adverse effect of heparin
therapy. Accurate and rapid HIT laboratory diagnosis when HIT is suspected is crucial. The …
therapy. Accurate and rapid HIT laboratory diagnosis when HIT is suspected is crucial. The …
Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7
GT Gerotziafas, V Galea, E Mbemba, A Khaterchi… - Thrombosis research, 2012 - Elsevier
Cancer histology influences the risk of venous thromboembolism and tissue factor (TF) is the
key molecule in cancer-induced hypercoagulability. We investigated the relation between …
key molecule in cancer-induced hypercoagulability. We investigated the relation between …
[HTML][HTML] Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer
…, P Van Dreden, A Khaterchi… - International …, 2017 - spandidos-publications.com
Hypercoagulablity is a common alteration of blood coagulation in cancer patients. However,
the procoagulant activity of cancer cells is not sufficient to induce hypercoagulability. The …
the procoagulant activity of cancer cells is not sufficient to induce hypercoagulability. The …
Effect of low molecular weight heparins and fondaparinux upon thrombin generation triggered by human pancreatic cancer cells BXPC3
…, M Sassi, MP Roman, A Khaterchi… - Current Vascular …, 2014 - ingentaconnect.com
Low molecular weight heparins (LMWHs) and fondaparinux are widely used for prophylaxis
and treatment of venous thromboembolic disease in cancer patients. However, the …
and treatment of venous thromboembolic disease in cancer patients. However, the …
Prospective evaluation of a rapid functional assay for heparin-induced thrombocytopenia diagnosis in critically ill patients
Objectives: Overdiagnosis of heparin-induced thrombocytopenia remains an unresolved
issue in the ICU leading to the unjustified switch from heparin to alternative anticoagulants or …
issue in the ICU leading to the unjustified switch from heparin to alternative anticoagulants or …
[HTML][HTML] Steady State Sickle Cell Anemia Is Associated with Increased Formation of Erythrocyte-Derived Microparticles and Acceleration of Thrombin Generation.
M Chaari, K Stankovic, V Galea, F Robert, A Khaterchi… - Blood, 2009 - Elsevier
Abstract 4001 Poster Board III-937 Introduction Patients with Sickle Cell Anemia (SCA) are
at risk of thrombosis, but this clinical manifestation is variable and it is probably not …
at risk of thrombosis, but this clinical manifestation is variable and it is probably not …
Organizational impact of an ID NOW™ COVID-19 point-of-care testing for SARS-CoV2 detection in a maternity ward
JCN Van, B Pilmis, A Khaterchi, O Billuart… - medRxiv, 2022 - medrxiv.org
Background SARS-CoV-2 has been responsible for more than 550 million cases of COVID-19
worldwide. RT-PCR is considered the “gold standard” for the diagnosis of patients …
worldwide. RT-PCR is considered the “gold standard” for the diagnosis of patients …
